Agency Forms Undergoing Paperwork Reduction Act Review, 17412-17414 [2018-08166]

Download as PDF 17412 Federal Register / Vol. 83, No. 76 / Thursday, April 19, 2018 / Notices Lenexa, Kansas; James R. Randall and Linda Randall, jointly with rights of survivorship, Osceola, Iowa; James Michael Randall, Stilwell, Kansas; Jennifer J. Main, N. Charleston, South Carolina; Jay T. Randall, Dunlap, Iowa; Lynn J. Randall, Dunlap, Iowa; and the Estate of Richard Randall, Dunlap, Iowa; to retain shares of Dunlap Holding company and thereby retain shares of Community Bank, both of Dunlap, Iowa. Board of Governors of the Federal Reserve System, April 16, 2018. Ann Misback, Secretary of the Board. [FR Doc. 2018–08226 Filed 4–18–18; 8:45 am] BILLING CODE P FEDERAL RESERVE SYSTEM daltland on DSKBBV9HB2PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 14, 2018. A. Federal Reserve Bank of Dallas (Robert L. Triplett III, Senior Vice President) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. Overton Financial Corporation, Overton, Texas, and Overton Delaware Corporation, Overton, Texas; to acquire up to 37.8 percent of the voting shares VerDate Sep<11>2014 17:49 Apr 18, 2018 Jkt 244001 of Longview Financial Corporation, Longview, Texas, and indirectly acquire shares of Texas Bank and Trust Company, Longview, Texas. Board of Governors of the Federal Reserve System, April 16, 2018. Ann Misback, Secretary of the Board. Board of Governors of the Federal Reserve System, April 13, 2018. Ann Misback, Secretary of the Board. [FR Doc. 2018–08227 Filed 4–18–18; 8:45 am] [FR Doc. 2018–08142 Filed 4–18–18; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM Centers for Disease Control and Prevention [30Day–18–0978] Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 18, 2018. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Plains Bancshares, Inc., Plains, Kansas; to merge with Sixth Bancshares, Inc., Salina, Kansas, and thereby indirectly acquire Bank VI, Salina, Kansas. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Emerging Infections Program (EIP) to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on December 21, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and E:\FR\FM\19APN1.SGM 19APN1 17413 Federal Register / Vol. 83, No. 76 / Thursday, April 19, 2018 / Notices instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Emerging Infections Program (OMB Control Number 0920–0978 Expiration Date 2/28/2019)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. CDC seeks a three-year OMB approval for this revised information collection project request. Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease. The total estimated time burden for the revised collection project is 40,347 hours, an increase of 18,257 hours. The majority of the collection activities remain the same, however, there are multiple proposed revisions including form consolidation, minor revised language and rewording to improve clarity and readability of the data collection forms and the discontinuation of the previously approved Legionellosis Expanded Case Report Form. CDC seeks to request the use of five new forms: ABCs Severe GAS Infection Supplemental Form; HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-resistant Pseudomonas aeruginosa (CR–PA); HAIC Multi-site Gram-Negative Surveillance Initiative— Extended-Spectrum Beta-LactamaseProducing Enterobacteriaceae (MuGSI– ESBL); HAIC Invasive Methicillinsensitive Staphylococcus aureus (MSSA); and HAIC Candidemia Case Report Form. These forms will allow the EIP to better detect, identify, and monitor emerging pathogens. This revision package will enhance the previous submission by improving surveillance through new forms, form consolidation, minor revised language to improve clarity, and the discontinuation of specific previously approved forms. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name State Health Department ................................ daltland on DSKBBV9HB2PROD with NOTICES Type of respondents ABCs Case Report Form ............................... ABCs Invasive Pneumococcal Disease in Children Case Report Form. ABCs Surveillance for Non-Invasive Pneumococcal Pneumonia (SNiPP) Case Report Form. ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form. ABCs Severe GAS Infection Supplemental Form—NEW FORM. ABCs Neonatal Infection Expanded Tracking Form. FoodNet Campylobacter ................................ FoodNet Cryptosporidium .............................. FoodNet Cyclospora ...................................... FoodNet Listeria monocytogenes .................. FoodNet Salmonella ....................................... FoodNet Shiga toxin producing E. coli .......... FoodNet Shigella ............................................ FoodNet Vibrio ............................................... FoodNet Yersinia ........................................... FoodNet Hemolytic Uremic Syndrome .......... Influenza Hospitalization Surveillance Network Case Report Form. Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English). Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish). Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults). HAIC CDI Case Report Form ........................ VerDate Sep<11>2014 17:49 Apr 18, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\19APN1.SGM Number of responses per respondent Average burden per response (in hours) 10 10 809 22 20/60 10/60 10 125 10/60 10 6 10/60 10 136 20/60 10 37 20/60 10 10 10 10 10 10 10 10 10 10 10 850 130 3 13 827 190 290 25 30 10 1000 21/60 10/60 10/60 20/60 21/60 20/60 10/60 10/60 10/60 1 25/60 10 333 5/60 10 333 5/60 10 333 5/60 10 1650 30/60 19APN1 17414 Federal Register / Vol. 83, No. 76 / Thursday, April 19, 2018 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Type of respondents HAIC Multi-site Gram-Negative Bacilli Case Report Form (MuGSI–CRE/CRAB). HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-resistant Pseudomonas aeruginosa(CR–PA)—NEW FORM. HAIC Multi-site Gram-Negative Surveillance Initiative—Extended-Spectrum BetaLactamase-Producing Enterobacteriaceae (MuGSI–ESBL)—NEW FORM. HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA). HAIC Invasive Methicillin-sensitive Staphylococcus aureus (MSSA)—NEW FORM. HAIC Candidemia Case Report Form—NEW FORM. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018–08166 Filed 4–18–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–18–17BAW] daltland on DSKBBV9HB2PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled the Paul Coverdell National Acute Stroke Program (PCNASP) 2015–2020 Assessment to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on October 10, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary VerDate Sep<11>2014 17:49 Apr 18, 2018 Jkt 244001 for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Paul Coverdell National Acute Stroke Program (2015–2020) Assessment— New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Number of responses per respondent Number of respondents Form name Average burden per response (in hours) 10 500 20/60 10 344 45/60 10 1200 20/60 10 609 20/60 10 1,035 20/60 9 800 20/60 Background and Brief Description The Centers for Disease Control and Prevention (CDC), Division for Heart Disease and Stroke Prevention (DHDSP), requests OMB approval for a new collection. The CDC is the primary Federal agency for protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. CDC is committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people. Stroke remains a leading cause of serious, long-term disability and is the fifth leading cause of death in the United States after heart disease, cancer, chronic lower respiratory diseases, and accidents. Estimates indicate that approximately 795,000 people suffer a first-ever or recurrent stroke each year with more than 130,000 deaths annually. Although there have been significant advances in preventing and treating stroke, the rising prevalence of heart disease, diabetes, and obesity has increased the relative risk for stroke, especially in African American populations. Moreover, stroke’s lifetime direct cost of health care and indirect cost of lost productivity is staggering and imposes a substantial societal economic burden. Coverdell-funded state programs are in the forefront of developing and implementing systemchange efforts to improve emergency response systems, enhance the quality of care for stroke, and improve transitions across stroke systems of care, including pre-event; transitions from EMS to acute care in hospitals; and transitions from hospitals to home, E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 83, Number 76 (Thursday, April 19, 2018)]
[Notices]
[Pages 17412-17414]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08166]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-18-0978]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Emerging Infections Program (EIP) to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on December 21, 2017 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and

[[Page 17413]]

instruments, call (404) 639-7570 or send an email to [email protected]. 
Direct written comments and/or suggestions regarding the items 
contained in this notice to the Attention: CDC Desk Officer, Office of 
Management and Budget, 725 17th Street NW, Washington, DC 20503 or by 
fax to (202) 395-5806. Provide written comments within 30 days of 
notice publication.

Proposed Project

    Emerging Infections Program (OMB Control Number 0920-0978 
Expiration Date 2/28/2019)--Revision--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases.
    CDC seeks a three-year OMB approval for this revised information 
collection project request.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies. Activities of the EIPs are designed to: (1) Address 
issues that the EIP network is particularly suited to investigate; (2) 
maintain sufficient flexibility for emergency response and new problems 
as they arise; (3) develop and evaluate public health interventions to 
inform public health policy and treatment guidelines; (4) incorporate 
training as a key function; and (5) prioritize projects that lead 
directly to the prevention of disease.
    The total estimated time burden for the revised collection project 
is 40,347 hours, an increase of 18,257 hours. The majority of the 
collection activities remain the same, however, there are multiple 
proposed revisions including form consolidation, minor revised language 
and rewording to improve clarity and readability of the data collection 
forms and the discontinuation of the previously approved Legionellosis 
Expanded Case Report Form.
    CDC seeks to request the use of five new forms: ABCs Severe GAS 
Infection Supplemental Form; HAIC Multi-site Gram-Negative Bacilli Case 
Report Form for Carbapenem-resistant Pseudomonas aeruginosa (CR-PA); 
HAIC Multi-site Gram-Negative Surveillance Initiative--Extended-
Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL); HAIC 
Invasive Methicillin-sensitive Staphylococcus aureus (MSSA); and HAIC 
Candidemia Case Report Form. These forms will allow the EIP to better 
detect, identify, and monitor emerging pathogens.
    This revision package will enhance the previous submission by 
improving surveillance through new forms, form consolidation, minor 
revised language to improve clarity, and the discontinuation of 
specific previously approved forms. There is no cost to respondents 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
        Type of respondents                   Form name              Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department............  ABCs Case Report Form......              10             809           20/60
                                     ABCs Invasive Pneumococcal               10              22           10/60
                                      Disease in Children Case
                                      Report Form.
                                     ABCs Surveillance for Non-               10             125           10/60
                                      Invasive Pneumococcal
                                      Pneumonia (SNiPP) Case
                                      Report Form.
                                     ABCs H.influenzae Neonatal               10               6           10/60
                                      Sepsis Expanded
                                      Surveillance Form.
                                     ABCs Severe GAS Infection                10             136           20/60
                                      Supplemental Form--NEW
                                      FORM.
                                     ABCs Neonatal Infection                  10              37           20/60
                                      Expanded Tracking Form.
                                     FoodNet Campylobacter......              10             850           21/60
                                     FoodNet Cryptosporidium....              10             130           10/60
                                     FoodNet Cyclospora.........              10               3           10/60
                                     FoodNet Listeria                         10              13           20/60
                                      monocytogenes.
                                     FoodNet Salmonella.........              10             827           21/60
                                     FoodNet Shiga toxin                      10             190           20/60
                                      producing E. coli.
                                     FoodNet Shigella...........              10             290           10/60
                                     FoodNet Vibrio.............              10              25           10/60
                                     FoodNet Yersinia...........              10              30           10/60
                                     FoodNet Hemolytic Uremic                 10              10               1
                                      Syndrome.
                                     Influenza Hospitalization                10            1000           25/60
                                      Surveillance Network Case
                                      Report Form.
                                     Influenza Hospitalization                10             333            5/60
                                      Surveillance Project
                                      Vaccination Phone Script
                                      Consent Form (English).
                                     Influenza Hospitalization                10             333            5/60
                                      Surveillance Project
                                      Vaccination Phone Script
                                      Consent Form (Spanish).
                                     Influenza Hospitalization                10             333            5/60
                                      Surveillance Project
                                      Provider Vaccination
                                      History Fax Form (Children/
                                      Adults).
                                     HAIC CDI Case Report Form..              10            1650           30/60

[[Page 17414]]

 
                                     HAIC Multi-site Gram-                    10             500           20/60
                                      Negative Bacilli Case
                                      Report Form (MuGSI-CRE/
                                      CRAB).
                                     HAIC Multi-site Gram-                    10             344           45/60
                                      Negative Bacilli Case
                                      Report Form for Carbapenem-
                                      resistant Pseudomonas
                                      aeruginosa(CR-PA)--NEW
                                      FORM.
                                     HAIC Multi-site Gram-                    10            1200           20/60
                                      Negative Surveillance
                                      Initiative--Extended-
                                      Spectrum Beta-Lactamase-
                                      Producing
                                      Enterobacteriaceae (MuGSI-
                                      ESBL)--NEW FORM.
                                     HAIC Invasive Methicillin-               10             609           20/60
                                      resistant Staphylococcus
                                      aureus (MRSA).
                                     HAIC Invasive Methicillin-               10           1,035           20/60
                                      sensitive Staphylococcus
                                      aureus (MSSA)--NEW FORM.
                                     HAIC Candidemia Case Report               9             800           20/60
                                      Form--NEW FORM.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-08166 Filed 4-18-18; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.